Abstract
Prescribing of Low-density Lipoprotein Cholesterol-lowering Therapies and Eligibility for Use of Proprotein Convertase Subtilisin/kexin Type 9 Monoclonal Antibodies Early After ST-elevation Myocardial Infarction
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
